Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67.09 USD | -0.06% | -0.19% | +7.81% |
May. 16 | Axonics Implant Approved in Australia to Treat Overactive Bladders | MT |
May. 16 | Axonics, Inc. Receives Regulatory Approval for Recharge-Free SNM System in Australia | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.81% | 3.42B | |
+13.73% | 130B | |
-8.17% | 10.99B | |
-4.33% | 8.35B | |
+41.80% | 5.67B | |
-21.94% | 4.72B | |
-10.26% | 2.76B | |
-10.29% | 2.11B | |
-13.58% | 1.92B | |
-27.77% | 1.68B |
- Stock Market
- Equities
- AXNX Stock
- News Axonics, Inc.
- Axonics, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2021